EMPA
CAS No. 680590-49-2
EMPA ( —— )
Catalog No. M22180 CAS No. 680590-49-2
EMPA is a selective, high-affinity and reversible antagonist of orexin OX2 receptor(human and rat OX2-HEK293 membranes with KD values of 1.1 and 1.4 nM respectively)EMPA displaces the EMPA binding from cell membranes containing human and rat OX2 receptors, with Ki values of 1.10±0.24 nM and 1.45±0.13 nM, respectively.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 102 | In Stock |
|
10MG | 159 | In Stock |
|
25MG | 313 | In Stock |
|
50MG | 462 | In Stock |
|
100MG | 660 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEMPA
-
NoteResearch use only, not for human use.
-
Brief DescriptionEMPA is a selective, high-affinity and reversible antagonist of orexin OX2 receptor(human and rat OX2-HEK293 membranes with KD values of 1.1 and 1.4 nM respectively)EMPA displaces the EMPA binding from cell membranes containing human and rat OX2 receptors, with Ki values of 1.10±0.24 nM and 1.45±0.13 nM, respectively.?
-
DescriptionEMPA is a selective, high-affinity and reversible antagonist of orexin OX2 receptor(human and rat OX2-HEK293 membranes with KD values of 1.1 and 1.4 nM respectively)EMPA displaces the EMPA binding from cell membranes containing human and rat OX2 receptors, with Ki values of 1.10±0.24 nM and 1.45±0.13 nM, respectively.??EMPA shows an IC50=5.75 μM, Ki=2.63 μM, and IC50=12.8 μM, Ki=5.8 μM in the binding assay at human and mouse V1a receptors, respectively.?In CHO(dHFr-) cells stably expressing hOX2 receptors, EMPA inhibits orexin-A-or orexin-B-evoked [Ca2+]i response with IC50s of 8.8±1.7 nM and 7.9±1.7 nM, respectively.EMPA competitively antagonizes orexin-A-and orexin-B-evoked accumulation of inositol phosphates (IP) at hOX2 receptors with pA2 values of 8.6 and 8.8 respectively.?EMPA (3-30 mg/kg;?i.p.) induces a significant and dose-dependent reduction in the baseline LMA in france and male Wistar rats.?EMPA (3-30 mg/kg;?i.p.) demonstrates a clear dose-dependent inhibition of spontaneous activity as compared with vehicle-treated animals.EMPA (1-300 mg/kg; i.p.) dose-dependently reverses this [Ala11,D-Leu15]orexin-B-induced hyperlocomotion without itself significantly affecting locomotor activity (LMA) in male NMRI mice.?
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOX2 Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number680590-49-2
-
Formula Weight454.54
-
Molecular FormulaC23H26N4O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:230 mg/mL (506 mM; Need ultrasonic)
-
SMILESCCN(Cc1cccnc1)C(=O)CN(c1ccc(OC)nc1)S(=O)(=O)c1ccccc1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. P Malherbe, et al. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX
molnova catalog
related products
-
Methyl 4-aminobutyra...
Methyl 4-aminobutanoate (GABA methyl ester) is a methyl ester compound derived from the condensation of aminobutyric acid and methanol.
-
[(1(10)E,2R,4R)]-2-M...
[(1(10)E,2R,4R)]-2-Methoxy-8,12-epoxygemacra-1(10),7,11-trien-6-one is a natural product.
-
2'-Deoxycytidine 5'-...
2'-Deoxycytidine 5'-monophosphate (dCMP) is used as a substrate of uridine monophosphate (UMP)/cytidine monophosphate (CMP) kinase (EC 2.7.4.4) to form dCDP which upon phosphorylation to dCTP supports DNA biosynthesis.